Improved Luminal Dimensions and Local Pharmacological Therapy with Laser Balloon Angioplasty for Potential Mitigation of Angioplasty Restenosis
Author:
Spears J. Richard
Publisher
Springer Netherlands
Reference22 articles.
1. Ross R (1986) The pathogenenis of atherosclerosis-an update. N Engl J Med 314:488–500 2. Nobuyoshi M, Kimura T, Ohishi H, Horiuchi H, Nosaka H, Hamasaki N, Yokoi H, Kim K (1991) Restenosis after percutaneous transluminal coronary angioplasty: pathologic observations in 20 patients. J Am Coll Cardiol 17:433–9 3. Schatz R A, Baim D S, Leon M, Ellis S G, Goldberg S, Hirshfeld J W, Cleman M W, Walker C, Stagg J et al (1991) Clinical experience with the Palmaz-Schatz coronary stent. Initial results of a multicenter study. Circulation 83:148–61 4. Spears J R, Reyes V P, Wynne J, Fromm B S, Sinofsky E L, Andrus S, Sinclair I N, Hopkins B E, Schwartz L, Aldridge H E, Plokker H W T, Mast E G, Rickards A, Knudtson M L, Sigwart L, Dear W E, Ferguson J J, Angelini P, Leatherman L L, Salan R D, Jenkins R D, Douglas J S, King III S B (1990) Percutaneous coronary laser balloon angioplasty: Initial results of a multicenter experience. JACC 16:293–303 5. Spears J R, Kundu S K, McMath L P (1991) Laser balloon angioplasty: Potential for reduction of thrombogenicity of the impaired arterial wall and for local application of bioprotective materials. JACC (in press)
|
|